Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vivani Medical Inc VANI

Healthcare Medical Devices
Vivani Medical, Inc. is a biopharmaceutical company developing novel, ultra-long-acting drug implants. Leveraging its NanoPortal platform, the Company develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and potentially to improve patient tolerance to their medication. Its lead program, NPM-115... see more

Recent & Breaking News (NDAQ:VANI)

Second Sight Receives Full FDA Approval to Begin First Orion Human Clinical Study

Business Wire November 2, 2017

Second Sight Announces Final Medicare Hospital Outpatient Payment Rate for 2018 for the Argus II Retinal Prosthesis System

Business Wire November 2, 2017

Second Sight to Discuss Third Quarter 2017 Financial Results on November 2, 2017 Conference Call

Business Wire October 26, 2017

Second Sight Announces Appointments of Frank Vandeputte as Vice President and General Manager, EMEA and Asia Pacific; Gregoire Cosendai as Vice President, Clinical Affairs

Business Wire October 19, 2017

Second Sight Receives Approval from Bundesinstitut für Arzneimittel und Medizinprodukte in Germany to Begin Study to Implant and Evaluate Argus II in Better-Sighted Retinitis Pigmentosa Patients

Business Wire October 17, 2017

Second Sight to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York on September 12th

Business Wire September 5, 2017

18 Biggest Mid-Day Gainers For Monday

Benzinga.com  August 28, 2017

Second Sight Receives Conditional FDA Approval to Begin First Orion Human Clinical Study

Business Wire August 28, 2017

Second Sight Reports Second Quarter 2017 Financial Results

Business Wire August 1, 2017

Investor Network: Second Sight Medical Products, Inc. to Host Earnings Call

Accesswire August 1, 2017

Second Sight Announces Market Entry into Russia with First Implant of Argus II Retinal Prosthesis System

Business Wire July 26, 2017

Second Sight to Discuss Second Quarter 2017 Financial Results on August 1, 2017 Conference Call

Business Wire July 20, 2017

Second Sight Announces Market Entry into South Korea with Two Implants and Performs Second Implant in Taiwan of Argus II Retinal Prosthesis System

Business Wire July 5, 2017

Medical Equipment Stock Performance Review -- Xtant Medical, Second Sight Medical Products, Lantheus, and Masimo

PR Newswire July 5, 2017

Second Sight Announces Expansion of Medicare Coverage for Argus II Retinal Prosthesis System to 11 Additional States and the District of Columbia

Business Wire July 3, 2017

Research Reports Initiation on Medical Equipment Stocks -- Corindus Vascular Robotics, InspireMD, Xtant Medical, and Second Sight Medical Products

PR Newswire May 23, 2017

Second Sight to Present at 18th Annual B. Riley & Co. Institutional Investor Conference

Business Wire May 17, 2017

Second Sight Reports First Quarter 2017 Financial Results

Business Wire May 3, 2017

Second Sight to Discuss First Quarter 2017 Financial Results on May 3, 2017 Conference Call

Business Wire April 25, 2017

La prothèse rétinienne Argus II de Second Sight implantée sur un premier patient en Asie

Business Wire April 13, 2017